Why Novavax Shares Are Falling After Hours

Novavax Inc NVAX shares are trading lower in Monday's after-hours session after the company reported worse-than-expected financial results.

Novavax reported first-quarter revenue of $704 million, which came in below the $845.2 million estimate, according to data from Benzinga Pro. The company reported quarterly earnings of $2.56 per share, which came in below the estimate of $2.69 per share. 

Novavax said the first quarter was its first profitable quarter as a commercial-stage company. The company reiterated full-year 2022 revenue guidance of $4 billion to $5 billion.

Novavax is a biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.

NVAX 52-Week Range: $42.13 - $277.79

The stock was down 7.06% in after-hours at $49.50 at press time.

Photo: Maryland GovPics from Flickr.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareMoversTrading IdeasGeneralwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!